PatternsRadar
Sign in

AMANTAAmanta Healthcare Limited

NSEASM Stage I
222.37INR-16.71 (-6.99%)Close · 20 Nov 2026
3 Nov 2026Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹863 CrMarket cap
47.1P/E (TTM)
40.9%Delivery

Filings & corporate actions

8 results filed
CSV
Next results · Q3 FY27
Expected 3 Feb 2027 – 30 Mar 2027
Estimate: filed 34–89 days after quarter end, last 6 times
2026
  • 3 NovresultsResults · Q2 FY27 · standalone+7.2%NSE
  • 14 OctshareholdingShareholding · 30 Sept 2026+5.0%NSE
  • 5 AugresultsResults · Q1 FY27 · standalone-2.0%NSE
  • 18 JulshareholdingShareholding · 30 Jun 2026-2.0%NSE
  • 29 MayresultsResults · Q3 FY26 · standalone-3.4%NSE
  • 29 MayresultsResults · Q4 FY26 · standalone-3.4%NSE
  • 19 MayresultsResults · Q4 FY26 · standalone-4.5%NSE
  • 20 AprshareholdingShareholding · 31 Mar 2026+4.0%NSE
  • 10 FebresultsResults · Q3 FY26 · standalone+2.1%NSE
  • 20 JanshareholdingShareholding · 31 Dec 2025-2.5%NSE
  • 12 JanresultsResults · Q2 FY26 · standalone-0.7%NSE

Reaction to results · all yearsrose on day 0 in 3 of 6 CSV

QuarterFiledDay 0+5D+20DRel vol
Q2 FY273 Nov 2026+7.2%+13.7%—5.1×
Q1 FY275 Aug 2026-2.0%-11.4%+10.0%0.2×
Q4 FY2619 May 2026-4.5%-0.4%+12.5%0.7×
Q3 FY2610 Feb 2026+2.1%0.0%-8.0%1.7×
Q2 FY2611 Nov 2025-0.4%-5.0%-16.4%0.5×
Q1 FY2627 Sept 2025+1.4%-0.4%-11.3%—
Average+0.6%-0.6%-2.7%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q2 FY27

Revenue YoY+17.3%
Profit YoY+302.5%
Interest cost YoY—
Revenue QoQ+20.8%
Profit QoQ+46.8%
CAGR2Y3Y4Y5Y6Y7Y
Revenue——————
Profit——————

Key data

Open241.00
Day range217.70 – 241.40
52-week range92.00 – 245.70
From 52w high-9.5%
RSI (14)59.2
ATR (14)15.62
Volume1.96L
Avg volume (20D)3.65L
Rel volume0.54×
Volatility (1Y)48.9%
Turnover₹4.4Cr
Traded value (NSE)₹4.4Cr
VWAP227.24
SMA 50 / 200191.25 / 151.95
Price band20%

Delivery percentage

Latest · 20 Nov 202640.9%
20-day avg42.4%
1-year avg71.4%
Percentile (own history)8th
Range9.7–100.0%
Sessions298

Over the last 20 sessions AMANTA settled 42.4% of its traded quantity, which is ordinary for an NSE equity. Its one-year average is 71.4%, so recent sessions are running 29.0 points lower than usual. The latest session ranks higher than 8% of the 298 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield0.00%
Dividend, trailing 12M₹0.00
Paid every year for0 yr
Shareholders12.3K · -2.3% QoQ
Net bulk deals, 30D0.00%
Block deals, 30D₹0
Last bulk buy162 days ago

Performance returns

1D1W1M3M6M1Y
Price-6.99%-5.16%+34.87%+19.23%+76.15%+85.59%

Valuation

Market cap₹863 Cr
Market cap (NSE)₹863 Cr
Free-float cap₹313 Cr
P/E (TTM)47.1
P/E (NSE)50.6
EPS (TTM)4.72
P/B3.8
Net margin (TTM)6.0%
Other income / PBT14.8%
ROE8.4%
Debt / equity0.86
Shares outstanding3.88Cr
Listed9 Sept 2025

Ownership

Promoter63.80%
Promoter Δ QoQ0.00 pp
Public36.20%
FII0.07%
DII12.20%
Pledged0.00%

Quarterly results · standalone

Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Revenue (₹ Cr)74.577.068.883.1
YoY chg——+5.4%+17.3%
Net profit (₹ Cr)4.65.53.34.9
YoY chg——-5.6%+302.5%
Net margin6.2%7.2%4.8%5.8%
EPS1.351.610.851.25

Shareholding over time

By quarter

30 Sept 2026 · promoter 63.80% · public 36.20%
8 Sept 2025: promoter 63.56%30 Sept 2025: promoter 63.56%31 Dec 2025: promoter 63.56%31 Mar 2026: promoter 63.72%30 Jun 2026: promoter 63.80%30 Sept 2026: promoter 63.80%
2025-092026-09
  • Promoter
  • Public and others
Promoter
63.80%
Public
36.20%
Promoter change
0.00 pp
Filed
14 Oct 2026
FII
0.07%
DII
12.20%
Promoter pledged
0.00%

Who the public is

Mutual funds
5.12%

-0.21 pp QoQ

Insurance
0.00%

0.00 pp QoQ

FPI
0.07%

-0.36 pp QoQ

Retail ≤ ₹2L
11.33%

+1.24 pp QoQ

HNI > ₹2L
6.98%

-0.38 pp QoQ

NRI
1.28%

+0.17 pp QoQ

Bodies corporate
1.54%

+0.36 pp QoQ

Shareholders
12,319

-2.3% QoQ

Major holders

As of 30 Sept 2026
HolderTypeHolding
Bhavesh Girishbhai PatelPromoter · Individual16.31%
Vishal Ashokkumar PatelPromoter · Individual10.06%
Jitendrakumar Jashbhai PatelPromoter · Individual9.02%
Milcent Appliances Private LimitedPromoter · Corporate7.98%
Praful Jashbhai PatelPromoter · Individual5.88%
Bandhan Small Cap FundMutual fund5.12%
Shailesh Mansukhlal MehtaPromoter · Individual4.46%
Niranjanbhai Ishwarbhai PatelPromoter · Individual3.88%
Kirit Ambalal DesaiPromoter · Individual3.29%
Jayshreeben Rohitkumar PatelPromoter · Individual2.57%

Every promoter-group member, and each public holder above 1%, as filed.

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.

52-week highs & lows

Loading…

Each session the stock traded past its previous 52-week high or low, from NSE's daily report; the previous figure is the record it broke. Prices as published, not split-adjusted.

Price-band hits

Loading…

Sessions the stock closed at the limit of its daily price band, from NSE's end-of-day list. A stock pinned at the band could not trade past it that day.

Insider trades

Insiders net, 30d
₹0
Insiders net, 90d
₹0
Promoters net, 90d
₹0
Insider buyers, 90d
0
Last promoter buy
5 months ago
Disclosures on record
11
3 open-market of the newest 11
By year
BroadcastPersonSideSharesValuePriceHolding before → afterStakeRegulation
22 Jun 2026Jitendrakumar Jashbhai PatelPromoterBuy16.2K₹24.3L149.9834.86L → 35.02L9.02%+0.04 pp7(2)told 19 Jun 2026
18 Jun 2026Bhavesh Girishbhai PatelPromoterBuy4.6K₹7.0L150.3263.27L → 63.31L16.31%+0.01 pp7(2)told 17 Jun 2026
17 Jun 2026Kirit Ambalal DesaiPromoterSell5.0K₹7.9L157.3111.33L → 11.28L2.91%-0.01 pp7(2)told 17 Jun 2026

SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.

How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session

Filings

CSV
Loading…

Bulk & block deals · 11 Jun 2026

CSV
12 of 18 deals
By year
DateDealClientQuantityPriceValue
11 Jun 2026Sell · bulkNK SECURITIES RESEARCH PRIVATE LIMITED3.81L156.24₹5.9Cr
11 Jun 2026Buy · bulkNK SECURITIES RESEARCH PRIVATE LIMITED3.81L156.07₹5.9Cr
11 Jun 2026Buy · bulkSILVERLEAF CAPITAL SERVICES PRIVATE LIMITED2.62L159.04₹4.2Cr
11 Jun 2026Sell · bulkSILVERLEAF CAPITAL SERVICES PRIVATE LIMITED2.62L158.85₹4.2Cr
11 Jun 2026Buy · bulkALPHAGREP SECURITIES PRIVATE LIMITED2.19L156.56₹3.4Cr
11 Jun 2026Sell · bulkALPHAGREP SECURITIES PRIVATE LIMITED2.19L156.35₹3.4Cr
11 Jun 2026Sell · bulkBLITZQUANT RESEARCH LLP2.06L158.96₹3.3Cr
11 Jun 2026Buy · bulkBLITZQUANT RESEARCH LLP2.06L158.85₹3.3Cr
16 Apr 2026Sell · bulkMANSI SHARE AND STOCK BROKING PRIVATE LIMITED2.17L124.86₹2.7Cr
16 Apr 2026Buy · bulkMANSI SHARE AND STOCK BROKING PRIVATE LIMITED2.17L123.09₹2.7Cr
10 Nov 2025Buy · bulkMANSI SHARE AND STOCK BROKING PRIVATE LIMITED2.06L123.88₹2.6Cr
10 Nov 2025Sell · bulkMANSI SHARE AND STOCK BROKING PRIVATE LIMITED1.10L120.05₹1.3Cr

A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.

Every stock on this session →

Takeover-code disclosures

Loading…

Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.

Every stock on this session →

Short selling, lending & margin

Loading…

Shares bought on broker margin funding (MTF) and still held at the day’s end, and the amount brokers have lent against them.

Exchange surveillance

20 Nov 2026
  • Short-term ASM · Stage I · since 18 Nov 2026 — Short-term Additional Surveillance Measure: a sharp move over a few days; a higher margin applies while it lasts.
  • P/E > 50 (4 quarters) · since 19 Nov 2026 — P/E above 50 on the last four quarters’ earnings.

Price band: 20% · not in the F&O ban.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures · band changes.

Every stock on this session →

Financials · quarterly statement

Standalone
₹ crore, as filed
By year
 Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Revenue from operations65.370.974.577.068.883.1
Other income1.00.10.71.70.60.8
Total income66.371.075.278.769.483.9
Total expenses61.366.168.971.065.077.1
└ Finance costs6.35.25.14.26.05.8
└ Depreciation4.64.74.74.84.75.3
Profit before tax4.92.36.37.64.56.8
Tax expense1.41.11.72.11.22.0
Net profit3.51.24.65.53.34.9
EPS1.220.351.351.610.851.25
Net margin5.37%1.70%6.21%7.18%4.81%5.85%
PBT margin7.54%3.21%8.46%9.89%6.53%8.21%
Tax rate28.81%46.98%26.57%27.38%26.31%28.79%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 3 Nov 2026.

Balance sheet & cash flow · half-yearly

Standalone
₹ crore, as filed
By year

Balance sheet

 H1 FY26FY26H1 FY27
Total assets488.3558.0529.0
Current assets242.9237.7176.6
└ Cash & equivalents92.081.01.7
└ Other bank balances10.411.625.1
└ Current investments0.00.00.0
└ Trade receivables47.243.044.2
└ Inventories83.082.788.6
Total equity210.7220.2228.1
└ Attributable to owners210.7220.2228.1
└ Share capital38.838.838.8
Borrowings177.5234.4196.0
└ Current54.472.4147.0
└ Non-current123.1162.049.0
Trade payables36.335.933.3
Current liabilities119.5141.1215.7
Total liabilities277.6337.8300.8
Net debt75.1141.8169.2
Debt / equity0.841.060.86
Current ratio2.031.690.82

Cash flow, year to date

 H1 FY26FY26H1 FY27
Operating cash flow27.648.420.5
└ Capex(9.7)(80.2)(37.6)
Free cash flow17.9(31.7)(17.1)
Investing cash flow(16.6)(93.6)(48.4)
Financing cash flow80.7126.0(51.5)
└ Dividends paid(0.5)(0.4)0.0
└ Buybacks0.00.00.0
Net change in cash91.780.8(79.3)

From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.

Announcements & board meetings

Loading…

As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.

Every stock on this session →

AMANTA at a glance

  • AMANTA closed at ₹222.37 on 20 Nov 2026, -6.99% on the day, +85.6% over one year, 9.5% below its 52-week high of ₹245.7.
  • Delivery was 40.9% of traded quantity on 20 Nov 2026, the 8th percentile of its own 298 sessions with a reading (20-session average 42.4%, 1-year average 71.4%).
  • Market capitalisation is ₹863 crore at a trailing P/E of 47.1 (trailing EPS ₹4.72).
  • Q2 FY27 results (standalone, filed 3 Nov 2026): revenue ₹83 crore (+17.3% year on year), net profit ₹5 crore (+302.5%); the price moved +7.2% on the first session after.
  • Promoters held 63.80% at 30 Sept 2026, unchanged on the previous filing.
  • Q3 FY27 results are expected between 3 Feb 2027 and 30 Mar 2027, going by past filing dates — an estimate, not an announcement.

About

Macro sectorHealthcare
Basic industryPharmaceuticals
ISININE084K01015
SeriesEQ
Listed9 Sept 2025
IPO price126.00 · band Rs.120 to Rs.126
IPO listing9 Sept 2025
NSE market cap · 17 Nov 2026₹911 Cr
Free-float market cap (NSE)₹330 Cr
Shares outstanding (NSE)3.88Cr
History from9 Sept 2025
Sessions298

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.